Mauritius vs Serbia: Statin use vs. average non-HDL cholesterol levels
Mauritius
3.7
in 2018
Serbia
3.7
in 2018
Mauritius rank
12th
Serbia rank
12th
Statin use vs. average non-HDL cholesterol levels over time
- Mauritius
- Serbia
How they compare
Mauritius currently reports 3.7 against 3.7 in Serbia, a difference of 0.
Across all 39 years both countries report, Serbia has been ahead every year.
Mauritius ranks 12th and Serbia ranks 12th of 191 countries.
Serbia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Mauritius | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.89 | 4.17 | 0.28 | Serbia |
| 1990s | 3.79 | 4.29 | 0.5 | Serbia |
| 2000s | 3.7 | 4.1 | 0.4 | Serbia |
| 2010s | 3.7 | 3.86 | 0.1556 | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Mauritius or Serbia?
- Mauritius, at 3.7 against 3.7 in Serbia as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Mauritius and Serbia?
- 0, with Mauritius ahead.
- How many years of comparable data are there for Mauritius and Serbia?
- 39 years are reported by both, from 1980 to 2018.
- How do Mauritius and Serbia rank globally for statin use vs. average non-hdl cholesterol levels?
- Mauritius ranks 12th and Serbia ranks 12th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.